Opportunity Information: Apply for RFA AA 17 006
Apply for RFA AA 17 006
- The Department of Health and Human Services, National Institutes of Health in the education, health sector is offering a public funding opportunity titled "U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.273, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853.
- This funding opportunity was created on Jun 21, 2016.
- Applicants must submit their applications by Sep 13, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 12 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01) grant opportunity (Funding Opportunity Number RFA AA 17 006) is a discretionary research grant offered by the U.S. Department of Health and Human Services through the National Institutes of Health (NIH). The program is designed to support formal, collaborative research projects in which a United States institution partners directly with a Russian institution, coordinated in collaboration with the Russian Foundation for Basic Research (RFBR). The central purpose is to strengthen bilateral scientific partnerships while advancing research that can improve prevention and treatment outcomes for HIV/AIDS, including the many health conditions that commonly occur alongside HIV.
The scope of research emphasized under this announcement is broad but clearly focused on HIV/AIDS and related burdens, spanning both biomedical and bio-behavioral science. Projects are expected to generate new knowledge or improved understanding that could influence real-world approaches to HIV prevention, clinical management, or health outcomes. In addition to HIV itself, the FOA explicitly highlights HIV-associated co-infections, comorbidities, and complications, meaning applications may address the intersection of HIV with other infectious diseases, chronic conditions, and clinical or social factors that worsen disease progression or interfere with care. The intent is not only to study HIV in isolation, but to tackle the complex, overlapping conditions that shape patient outcomes and public health impact.
This is an R01 mechanism, meaning it is intended for robust, hypothesis-driven research projects with a defined set of aims and a clear plan for implementation, collaboration, and analysis. The announcement anticipates making about 12 awards, with an award ceiling listed at $200,000. While the FOA description points to collaborative partnership as a core requirement, the structure implies that the U.S. applicant institution submits an NIH application while coordinating closely with the Russian partner and the RFBR collaboration framework, aligning the scientific goals and roles across both countries.
Eligibility is intentionally expansive. Applicants may include many types of U.S.-based organizations, such as public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (other than small businesses as well as small businesses), and multiple levels of government entities (state, county, city/township, special district), along with certain tribal governments and tribal organizations, and public housing authorities/Indian housing authorities. This wide eligibility suggests the program is open to universities, medical centers, research institutes, public health agencies, and other research-capable organizations, as long as they can credibly execute an HIV-focused research project and maintain a qualified Russian institutional partnership.
Key administrative details include an NIH creation date of June 21, 2016, with an original closing date of September 13, 2016. The listing includes multiple CFDA numbers (93.242, 93.273, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853), indicating the opportunity touches several NIH program areas and institutes/centers that support HIV/AIDS and related research domains. Overall, the grant is best understood as a targeted, partnership-driven NIH research funding opportunity intended to produce impactful HIV/AIDS science while deepening coordinated U.S.-Russia research ties, particularly in areas where co-infections, comorbidities, and complications create major barriers to prevention and effective treatment.
FAQs: U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on HIV/AIDS (R01)
What is the name of this grant opportunity?
The opportunity is titled U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA AA 17 006.
Which federal agency offers this opportunity?
It is offered by the U.S. Department of Health and Human Services (HHS) through the National Institutes of Health (NIH).
What type of grant mechanism is this?
This is an R01 research grant mechanism, intended for robust, hypothesis-driven research projects with defined aims and a clear plan for implementation, collaboration, and analysis.
Is this a discretionary grant?
Yes. The opportunity is described as a discretionary research grant.
What is the main purpose of the program?
The central purpose is to strengthen bilateral scientific partnerships between U.S. and Russian institutions while advancing research that can improve HIV/AIDS prevention and treatment outcomes, including outcomes affected by HIV-associated comorbidities and related conditions.
What kind of collaboration is required?
Projects must be formal, collaborative research projects where a United States institution partners directly with a Russian institution, coordinated in collaboration with the Russian Foundation for Basic Research (RFBR).
Does the program focus only on HIV, or also on other related conditions?
It includes HIV and explicitly emphasizes HIV-associated co-infections, comorbidities, and complications. Applications may address intersections between HIV and other infectious diseases, chronic conditions, and clinical or social factors that worsen disease progression or interfere with care.
What research areas are supported under this announcement?
The scope is broad but clearly focused on HIV/AIDS and related burdens, spanning both biomedical and bio-behavioral science. Projects are expected to generate new knowledge or improved understanding that could influence real-world approaches to HIV prevention, clinical management, or health outcomes.
Is the intent to study HIV in isolation?
No. The stated intent is to go beyond HIV alone and address the complex, overlapping conditions that shape patient outcomes and public health impact, including co-infections, comorbidities, and complications.
How many awards does the announcement anticipate making?
The announcement anticipates making about 12 awards.
What is the award ceiling mentioned in the opportunity?
The award ceiling is listed at $200,000.
Who submits the NIH application?
The structure described implies that the U.S. applicant institution submits an NIH application, while coordinating closely with the Russian partner and the RFBR collaboration framework to align scientific goals and roles across both countries.
What types of U.S. organizations are eligible to apply?
Eligibility is described as intentionally expansive and includes many U.S.-based organization types, such as:
- Public and private institutions of higher education
- Nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities)
- For-profit organizations (including small businesses and other than small businesses)
- State, county, city/township, and special district governments
- Certain tribal governments and tribal organizations
- Public housing authorities/Indian housing authorities
What kinds of applicant organizations does this broad eligibility suggest?
Based on the eligibility categories listed, the program appears open to organizations such as universities, medical centers, research institutes, public health agencies, and other research-capable organizations, as long as they can credibly execute an HIV-focused research project and maintain a qualified Russian institutional partnership.
When was the NIH posting created?
The NIH creation date listed is June 21, 2016.
What was the original closing date for the opportunity?
The original closing date listed is September 13, 2016.
Which CFDA numbers are associated with this opportunity?
The listing includes multiple CFDA numbers: 93.242, 93.273, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853.
What do the multiple CFDA numbers indicate about the opportunity?
The multiple CFDA numbers suggest the opportunity touches several NIH program areas and institutes/centers that support HIV/AIDS and related research domains.
How should this opportunity be summarized in plain terms?
It is a targeted, partnership-driven NIH R01 research funding opportunity designed to produce impactful HIV/AIDS science while deepening coordinated U.S.-Russia research ties, particularly in areas where co-infections, comorbidities, and complications create major barriers to prevention and effective treatment.
Browse more opportunities from the same agency: Department of Health and Human Services, National Institutes of Health
Browse more opportunities from the same category: Education, Health
Next opportunity: ApprenticeshipUSA State Expansion Grants
Previous opportunity: Invasive Plant Crew
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AA 17 006
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AA 17 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cancer Target Discovery and Development Network (U01) Apply for RFA CA 16 014 Funding Number: RFA CA 16 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| U.S.-Russia Bilateral Collaborative Research Partnerships on Cancer (R21) Apply for RFA CA 16 015 Funding Number: RFA CA 16 015 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $100,000 |
| Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24) Apply for RFA CA 16 502 Funding Number: RFA CA 16 502 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24) Apply for RFA CA 16 017 Funding Number: RFA CA 16 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1) Apply for RFA CA 16 016 Funding Number: RFA CA 16 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
| FY 2017 American Schools and Hospitals Abroad (ASHA) Program (Request for Comments) Apply for APS ASHA 17 000001 Funding Number: APS ASHA 17 000001 Agency: Agency for International Development Category: Education, Health Funding Amount: $2,000,000 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) Apply for RFA CA 17 013 Funding Number: RFA CA 17 013 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) Apply for RFA CA 17 012 Funding Number: RFA CA 17 012 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) Apply for RFA CA 17 011 Funding Number: RFA CA 17 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24) Apply for RFA CA 17 004 Funding Number: RFA CA 17 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $650,000 |
| PDX Development and Trial Centers (PDTCs) (U54) Apply for RFA CA 17 003 Funding Number: RFA CA 17 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $800,000 |
| Mechanisms of Cancer Drug Resistance and Sensitivity (U54) Apply for RFA CA 17 009 Funding Number: RFA CA 17 009 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01) Apply for RFA CA 17 015 Funding Number: RFA CA 17 015 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24) Apply for RFA CA 17 016 Funding Number: RFA CA 17 016 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24) Apply for RFA CA 17 002 Funding Number: RFA CA 17 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Canine Immunotherapy Trials and Correlative Studies (U01) Apply for RFA CA 17 001 Funding Number: RFA CA 17 001 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp) Apply for PA 17 138 Funding Number: PA 17 138 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $135,000 |
| Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24) Apply for RFA NS 17 022 Funding Number: RFA NS 17 022 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $750,000 |
| NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3) Apply for RFA DA 18 003 Funding Number: RFA DA 18 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Intensive Longitudinal Analysis of Health Behaviors: Leveraging New Technologies to Understand Health Behaviors (U01) Apply for RFA OD 17 004 Funding Number: RFA OD 17 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AA 17 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.